Business Description
LongBio Pharma is a China-based biotechnology company focused on developing treatments for allergic and autoimmune diseases, operating primarily in mainland China and Hong Kong. Founded in 2020 and headquartered in Changshu, the company is currently in the clinical stage, working to bring several antibody-based drug candidates from research through to commercialization. Its pipeline includes a range of novel antibody and fusion protein therapies designed to target different aspects of the immune system across various conditions and tissues.
